Stockreport

AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]

Avita Medical, Inc.  (RCEL) 
PDF It was a pretty bad result overall; while revenues were in line with expectations at US$20m, statutory losses exploded to US$0.64 per share. The analysts typically updat [Read more]